Skip to content

Neuroplasticity of brain glutamate and glutamine and treatment response in alcoholism

Neuroplasticity of brain glutamate and glutamine and treatment response in alcoholism - SFB D7

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00003439
Enrollment
80
Registered
2012-01-16
Start date
2012-10-10
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F10.2

Interventions

Group 1: Alcohol dependent patients (according to ICD-10 and DSM-IV, SCID) are scanned with MR-spectroscopy the day of admission to a inpatient detoxification programm and again after 5 and again afte

Sponsors

Zentralinstitut für Seelische Gesundheit Klinik für Abhängiges Verhalten und Suchtmedizin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Legally effective, written informed consent for participation within the study, including ability to communicate with the researchers Alcohol dependent subjects: - Diagnose of alcohol dependence according to ICD-10 and DSM-IV Healthy controls: - no or minimal consumption of alcohol, - laboratory parameters sensitive for alcohol within normal range

Exclusion criteria

Exclusion criteria: Actual psychiatric disorder (Axis I) according to DSM-IV / ICD-10 (assessed with SCID-I) except nicotine abuse or nicotine dependence and alcohol dependence for patients - Positive drugscreen (opiates, cannabinoids, benzodiazepines, barbiturates, cocaine, amphetamine), - actual treatment with psychoactive medication, - MR contraindication (e.g. pacemaker, metallic or electronic implants, metal splinters…) - Severe physical disorders (liver-cirrhosis, severe diabetes), - former psychotic disorder, - actual suicidal tendency or endangerment of others

Design outcomes

Primary

MeasureTime frame
concentrations of glutamate, glutamine and GABA in the anterior cingulate cortex are assessed with MR-Spectroscopy at the beginning of acute alcohol withdrawal, after fife days of abstinence and after two weeks of abstinence

Secondary

MeasureTime frame
associations of metabolite concentrations in the anterior cingulate cortex at the beginning of acute alcohol withdrawal, after five days of abstinence and after two weeks of abstinence with cue-reactivity to alcoholrelated stimuli. Cue-reactivity will be assessed using functional Magnetic Resonance Imaging (fMRI).

Countries

Germany

Contacts

Public ContactDerik Hermann

Zentralinstitut für Seelische Gesundheit Klinik für Abhängiges Verhalten und Suchtmedizin

derik.hermann@zi-mannheim.de0621/17033541

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026